期刊
CURRENT DRUG METABOLISM
卷 13, 期 10, 页码 1412-1421出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138920012803762765
关键词
ACOX1; Coactivators; hepatic Steatosis; hepatocarcinogenesis; MED1; NASH; beta-oxidation; Peroxisome; Peroxisomes proliferation; PPARalpha
资金
- Institut national de la sante et de la recherche medicale
- Regional Council of Burgundy
- Ministere de l'enseignement superieur et de la recherche
- Centre National de la Recherche Scientifique
- Intramural Research Program of NIH, National Institute of Environmental Health Sciences, NIH intramural project [Z01ES02124]
Three subhepatocellular compartments concur for fatty acids degradation including omega-oxidation in endoplasmic reticulum and beta-oxidation in both mitochondria and peroxisomes. Deficits affecting the peroxisomal physiology may be associated with multiple metabolic disturbances. Nowadays, a growing body of evidence underlines the key role of peroxisomal beta-oxidation in the sensing of lipid metabolism through the production/degradation of some essential metabolites. Lessons from several mice models strengthen the link between fatty acid beta-oxidation in peroxisomes and the nuclear hormone receptor Peroxisome Proliferator-Activated Receptor (PPAR)-alpha with an additional level of coregualtor complexity, which couples regulation of body energetic balance and hepatic caloric flux to functional peroxisome status. Here, we review key determinants of disrupted peroxisomal beta-oxidation pathway, which in liver promotes hepatic steatosis and hepatocarcinogenesis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据